An unsettling picture emerges from the latest report by Fundsmith Equity Fund, a prominent investment management firm based in London, which has just released its annual investor letter for 2025. This isn’t just another bland financial statement; it cuts through the typically mundane financial jargon to reveal alarming trends that shake the core of their investment strategies.

The Fund claims that its T Class Accumulation shares only yielded a meager 0.8% return in 2025 compared to a remarkable 12.8% from the MSCI World Index. It begs the question: how can a fund with such a respectable reputation be so woefully outperformed? Fundsmith attributes its underperformance to factors like the increasing concentration of index fund assets and a distinct weakness in the value of the dollar. These responses feel like grasping at straws in a strategic blunder that shouldn’t have happened to a seasoned investment firm.

Among its portfolio, Fundsmith highlighted Brown-Forman Corporation (NYSE:BF-B), a well-known player in the alcohol sector. Here’s where the plot thickens: over just one month, Brown-Forman’s shares plummeted by a staggering 12.46%, with an even more shocking decline of 22.71% over the previous 52 weeks. As of January 12, 2026, the stock settled at a dismal $26.62 per share, leading to a market capitalization of $12.33 billion. What went wrong? Has confidence in this brand irreversibly declined?

Fundsmith didn’t hold back in its fourth-quarter narrative, pointing squarely at the double-edged sword of modern lifestyle changes. The firm suggests that both Brown-Forman and PepsiCo’s snack division are under siege from the trend of weight-loss drugs, which seem to alter consumer appetites. This revelation has a dual hit to the alcohol business, especially considering the changing drinking habits of Generation Z and the looming legalization of cannabis, which threatens to siphon off traditional beverage customers.

Is Brown-Forman Corporation truly the best alcohol stock to invest in, particularly as doubts arise among billionaires and hedge funds? Surprising to many, it was absent from Insider Monkey’s list of the 30 most popular stocks among hedge funds. Data reveals a decrease in hedge fund portfolios holding Brown-Forman from 37 to 35 over a single quarter. This drop could foreshadow a more profound distrust that even the tried-and-true confident investors harbor.

While certain AI stocks may currently hold greater promise, the looming question arises—Has the allure of alcohol stocks dimmed in favor of more innovative investments? Analysts contend that many tech-centric stocks could yield higher returns while mitigating risks. The scrutiny of Brown-Forman highlights a broader environmental shift that may well delineate the future of alcohol investment. The oncoming tide of evolving consumer behavior is making it abundantly clear: navigating these waters requires more than just hope; it demands a strategy that adapts to the transient economic reality.

In essence, the financial community must reflect on the implications of these changes rather than fixate on past returns. If Fundsmith and similar entities continue to sidestep these critical consumer insights, they not only risk financial loss but risk becoming obsolete in a fast-evolving market that increasingly prioritizes health and lifestyle.

Source: Insider Monkey

Source: finance.yahoo.com/news/why-fundsmith-equity-fund-sold-122126283.html